Skip to main content
. 2019 Nov 21;14(11):e0225575. doi: 10.1371/journal.pone.0225575

Fig 4. Frequency and levels of HIV-1 drug resistance to various antiretroviral drugs among ART-naïve patients.

Fig 4

NRTI: Nucleotide reverse transcriptase inhibitors [3TC: lamivudine; FTC: emtricitabine; ABC: abacavir; AZT: zidovudine; d4T: stavudine; ddl: didanosine; TDF: tenofovir]. NNRTI: Non-Nucleoside reverse transcriptase inhibitors [NVP: nevirapine; EFV: efavirenz; ETR: etravirine; RPV: rilpivirine]. Red represent high-level resistance, blue represent intermediate resistance, green represent low-level resistance and purple represent potential low-level resistance.